Acrivon TherapeuticsACRV
13F holders, Q1 2025 (March 31)63holders
7new positions
7sold out
2famous investors
$2.03avg. 13F price*
At the end of Q1 2025, 63 institutions reported holding Acrivon Therapeutics Inc. (ACRV) in their 13F filings, unchanged from Q4 2024. 7 opened new positions and 7 sold out. The largest holders were Ra Capital Management, L.P. ($16.9M), Perceptive Advisors LLC ($10.9M) and Sands Capital Alternatives, LLC ($4.3M). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Acrivon Therapeutics Inc.
- CUSIP
- 004890109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $149K |
| Exits | 7 | $945K |
All 13F filers, Q4 2024 → Q1 2025: 147,504 shares bought and 879,776 shares sold, net −732,272 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 63 holders
| Ra Capital Management, L.P. | 0.28% | No change | 8,340,508 | $16.9M |
| Perceptive Advisors LLC | 0.39% | No change | 5,360,858 | $10.9M |
| Sands Capital Alternatives, LLC | 1.05% | No change | 2,122,605 | $4.3M |
| Citadel Advisors | 0.00% | Reduce -10.6% | 1,895,519 | $3.8M |
| BlackRock, Inc. | 0.00% | Reduce -0.7% | 938,707 | $1.9M |
| Wellington Management Group LLP | 0.00% | No change | 888,130 | $1.8M |
| Vanguard Group Inc. | 0.00% | Add +0.5% | 674,790 | $1.4M |
| Marshall Wace, LLP | 0.00% | Reduce -24.7% | 450,391 | $914K |
| Acorn Capital Advisors, LLC | 0.55% | No change | 405,237 | $823K |
| Geode Capital Management, LLC | 0.00% | Add +1.6% | 306,111 | $622K |
| State Street Corp. | 0.00% | Reduce -1.7% | 232,551 | $472K |
| Charles Schwab Investment Management Inc. | 0.00% | Reduce -2.2% | 111,320 | $226K |
| Northern Trust Corp. | 0.00% | Reduce -7.1% | 109,025 | $221K |
| Bridgeway Capital Management, LLC | 0.00% | Add +4.4% | 77,900 | $158K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -75.8% | 57,519 | $117K |
| Wealthedge Investment Advisors, LLC | 0.05% | Add +420.1% | 56,467 | $115K |
| Renaissance Technologies | 0.00% | Add +5.5% | 52,100 | $106K |
| Dimensional Fund Advisors LP | 0.00% | Add +19.1% | 44,154 | $90K |
| Invesco Ltd. | 0.00% | New | 35,315 | $72K |
| Morgan Stanley | 0.00% | Add +1.4% | 35,221 | $71K |
| Barclays PLC | 0.00% | Reduce -14.2% | 32,698 | $66K |
| Bank of America Corp. | 0.00% | Reduce -10.9% | 27,699 | $56K |
| Bank of New York Mellon Corp | 0.00% | No change | 27,635 | $56K |
| Exchange Traded Concepts, LLC | 0.00% | Add +13.8% | 23,161 | $47K |
| Baker Bros. Advisors LP | 0.00% | Reduce -56.9% | 22,809 | $46K |
| American Century Companies Inc. | 0.00% | Reduce -1.2% | 17,381 | $35K |
| Rhumbline Advisers | 0.00% | Reduce -6.5% | 16,600 | $34K |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 0.00% | Reduce -84.8% | 15,576 | $32K |
| Susquehanna International Group, LLP | 0.00% | New | 14,580 | $30K |
| Marex Group Ltd | 0.00% | Add +6.8% | 14,080 | $29K |
| Nuveen, LLC | 0.00% | — | 13,402 | $27K |
| Prelude Capital Management, LLC | 0.00% | New | 13,067 | $27K |
| UBS Group AG | 0.00% | Reduce -9.3% | 12,888 | $26K |
| Citigroup Inc. | 0.00% | Reduce -9.5% | 11,159 | $23K |
| AAF Wealth Management, LLC | 0.01% | No change | 10,678 | $22K |
| Intech Investment Management LLC | 0.00% | New | 10,091 | $20K |
| JPMorgan Chase & Co. | 0.00% | Reduce -67.2% | 8,479 | $17K |
| Wells Fargo & Company | 0.00% | Add +2.3% | 7,090 | $14K |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | Add +4.6% | 7,087 | $14K |
| China Universal Asset Management Co., Ltd. | 0.00% | Reduce -5.4% | 6,245 | $13K |
| Corebridge Financial, Inc. | 0.00% | Reduce -1.5% | 5,787 | $12K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +75.0% | 3,090 | $6K |
| FMR LLC | 0.00% | Reduce -9.1% | 2,665 | $5K |
| New York State Common Retirement Fund | 0.00% | No change | 2,314 | $5K |
| BNP Paribas Financial Markets | 0.00% | Reduce -31.2% | 1,336 | $3K |
| Mirae Asset Global Investments Co., Ltd. | 0.00% | Add +0.4% | 1,042 | $2K |
| Royal Bank of Canada | 0.00% | Reduce -48.2% | 849 | $2K |
| Nisa Investment Advisors, LLC | 0.00% | Add +859.0% | 959 | $2K |
| California State Teachers Retirement System | 0.00% | No change | 856 | $2K |
| Legal & General Group Plc | 0.00% | No change | 839 | $2K |
| STRS Ohio | 0.00% | No change | 800 | $2K |
| GF Fund Management Co. LTD. | 0.00% | Add +18.0% | 772 | $2K |
| Ameritas Investment Partners, Inc. | 0.00% | No change | 695 | $1K |
| Deutsche Bank AG | 0.00% | New | 541 | $1K |
| Redwood Park Advisors LLC | 0.00% | No change | 500 | $1K |
| Amalgamated Bank | 0.00% | No change | 378 | $1K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 400 | $812 |
| GAMMA Investing LLC | 0.00% | Add +744.1% | 287 | $583 |
| Sterling Capital Management LLC | 0.00% | Reduce -50.6% | 198 | $402 |
| SBI Securities Co., Ltd. | 0.00% | No change | 74 | $150 |
| True Wealth Design, LLC | 0.00% | New | 3 | $7 |
| Cwm, LLC | 0.00% | Add +19.5% | 49 | $0 |
| Avion Wealth | 0.00% | New | 88 | $0 |
"% of holder's portfolio" is ACRV's weight in each manager's 13F, not the share of Acrivon Therapeutics Inc. the manager owns.